MIT Scientists Reboot Immune System with Liver

A groundbreaking study from MIT reveals a new method to rejuvenate aging immune systems. Researchers, led by neuroscientist Feng Zhang, engineered messenger RNA (mRNA) to instruct liver cells to produce vital signaling proteins. These proteins mimic natural thymus signals, prompting the regeneration of T-cells, which are essential for immune defense but decline with age.

Experiments in older mice showed remarkable results. The mRNA treatment, delivered via lipid nanoparticles to the liver, significantly boosted immune responses in vaccination and cancer immunotherapy models. This approach successfully increased the quantity and activity of T-cells, leading to improved vaccine efficacy and potent anti-tumor effects, with nearly half of treated mice overcoming tumors.

While the treatment's benefits require ongoing injections to be sustained, the MIT team views this method as a promising, generalizable strategy. Repurposing the liver to produce therapeutic proteins could offer a new avenue for addressing a wide range of age-related health conditions and diseases, potentially improving health outcomes globally.